IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock Holdings Raised by 1900 Wealth Management LLC

1900 Wealth Management LLC lifted its stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 6.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 775 shares of the company’s stock after purchasing an additional 50 shares during the period. 1900 Wealth Management LLC’s holdings in IDEXX Laboratories were worth $320,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. FSA Wealth Management LLC acquired a new position in shares of IDEXX Laboratories in the 3rd quarter worth approximately $25,000. E Fund Management Hong Kong Co. Ltd. lifted its stake in IDEXX Laboratories by 5,700.0% during the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 58 shares of the company’s stock worth $29,000 after purchasing an additional 57 shares during the last quarter. Retirement Wealth Solutions LLC acquired a new position in IDEXX Laboratories in the fourth quarter worth $31,000. Mowery & Schoenfeld Wealth Management LLC increased its stake in IDEXX Laboratories by 750.0% during the third quarter. Mowery & Schoenfeld Wealth Management LLC now owns 68 shares of the company’s stock valued at $34,000 after purchasing an additional 60 shares during the last quarter. Finally, Ashton Thomas Securities LLC bought a new stake in IDEXX Laboratories during the third quarter valued at $37,000. 87.84% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Sophie V. Vandebroek sold 344 shares of IDEXX Laboratories stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $420.44, for a total transaction of $144,631.36. Following the transaction, the director now directly owns 905 shares in the company, valued at approximately $380,498.20. This trade represents a 27.54 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 2.18% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently commented on the stock. Leerink Partners started coverage on shares of IDEXX Laboratories in a report on Monday, December 2nd. They issued an “outperform” rating and a $500.00 price target for the company. Bank of America lifted their target price on IDEXX Laboratories from $475.00 to $535.00 and gave the company a “neutral” rating in a research note on Tuesday. StockNews.com cut IDEXX Laboratories from a “buy” rating to a “hold” rating in a research report on Wednesday. Stifel Nicolaus cut their price target on IDEXX Laboratories from $510.00 to $500.00 and set a “hold” rating on the stock in a report on Thursday, October 10th. Finally, Piper Sandler reaffirmed a “neutral” rating and issued a $435.00 target price (down from $520.00) on shares of IDEXX Laboratories in a research report on Monday, November 4th. Four research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $524.38.

IDEXX Laboratories Trading Down 1.7 %

Shares of IDXX stock opened at $460.56 on Friday. IDEXX Laboratories, Inc. has a 1 year low of $398.50 and a 1 year high of $583.39. The firm has a market capitalization of $37.72 billion, a PE ratio of 44.41, a price-to-earnings-growth ratio of 3.64 and a beta of 1.37. The stock has a fifty day moving average of $426.81 and a two-hundred day moving average of $453.62. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.03 and a current ratio of 1.42.

About IDEXX Laboratories

IDEXX Laboratories, Inc develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.